Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

PROCEPT BioRobotics Corporation PRCT

Set alert

Price alert · PRCT

All alert types
19.44 USD +0.24 +1.25%

At close · Nov 2

19.44 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
19.45 × 2
Ask
19.46 × 2
19.09 Day range 19.85
16.67 52-week range 38.11
YTD
-38.21%
1 year
-42.87%
Open
19.33
Prev close
19.20
Mkt cap
1.11B
Vol
1.27M
Avg vol
1.35M
EPS
-1.94
P/E
0.00
Div yield
0.00%
More statistics
Low
19.09
High
19.85
Forward P/E
-16.59
Beta
0.84
Short ratio
5.27
Inst. own
98.43%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
19.40
200-d avg
23.32
1y target
22.25

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 4, 2026Earnings: -0.47; estimate -0.46186; surprise -1.76%
  • Aug 5, 2026Downgrade: William Blair · Outperform → Market Perform
  • Aug 5, 2026Rating: Evercore ISI Group · Outperform → Outperform
  • Aug 5, 2026Rating: Piper Sandler · Overweight → Overweight
  • Aug 5, 2026Rating: TD Cowen · Buy → Buy
  • Oct 7, 2026Rating: Barclays · — → Overweight
Signals (26)
NameDateAgo
SMA: BullishNov 2, 202620 hours ago
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 22, 20261 week ago
SMA: BullishOct 22, 20261 week ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BearishOct 13, 20262 weeks ago
SMA: BullishOct 12, 20263 weeks ago
MACD: Buy SignalOct 8, 20263 weeks ago
SMA: BearishSep 15, 20261 month ago
SMA: BearishSep 15, 20261 month ago
SMA: BullishSep 14, 20261 month ago
SMA: BullishSep 11, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BearishSep 9, 20261 month ago
MACD: Sell SignalSep 9, 20261 month ago
MACD: Buy SignalSep 2, 20262 months ago
MACD: Sell SignalAug 28, 20262 months ago
SMA: BullishAug 21, 20262 months ago
SMA: BearishAug 20, 20262 months ago

Newest 20 of 26.

Financial health

Altman Z-Score

3.59 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -18.3×
FY 2019: -33.6×FY 2020: -27.8×FY 2021: -18.3×FY 2022: -21.2×FY 2023: -18.7×FY 2024: -46.0×FY 2025: -18.3×
FY 2019 5y median -18.7× FY 2025
P/S 5.7×
FY 2019: 228×FY 2020: 191×FY 2021: 31.7×FY 2022: 24.6×FY 2023: 14.5×FY 2024: 18.7×FY 2025: 5.7×
FY 2019 5y median 18.7× FY 2025
P/B 4.8×
FY 2019: 48.2×FY 2020: 24.2×FY 2021: 4.1×FY 2022: 9.4×FY 2023: 7.1×FY 2024: 10.4×FY 2025: 4.8×
FY 2019 5y median 7.1× FY 2025
P/FCF -30.0×
FY 2019: -27.4×FY 2020: -30.3×FY 2021: -18.9×FY 2022: -22.2×FY 2023: -14.9×FY 2024: -40.5×FY 2025: -30.0×
FY 2019 5y median -22.2× FY 2025
EV/EBITDA -18.0×
FY 2019: -35.0×FY 2020: -31.8×FY 2021: -16.6×FY 2022: -21.5×FY 2023: -18.4×FY 2024: -48.1×FY 2025: -18.0×
FY 2019 5y median -18.4× FY 2025
EV/Sales 5.0×
FY 2019: 225×FY 2020: 185×FY 2021: 24.4×FY 2022: 22.6×FY 2023: 13.2×FY 2024: 17.6×FY 2025: 5.0×
FY 2019 5y median 17.6× FY 2025
FCF Yield -3.3%
FY 2019: -3.7%FY 2020: -3.3%FY 2021: -5.3%FY 2022: -4.5%FY 2023: -6.7%FY 2024: -2.5%FY 2025: -3.3%
FY 2019 5y median -4.5% FY 2025

Profitability

Gross Margin 63.7%
FY 2019: -30.6%FY 2020: -16.3%FY 2021: 46.0%FY 2022: 49.4%FY 2023: 52.2%FY 2024: 61.1%FY 2025: 63.7%
FY 2019 5y median 52.2% FY 2025
Operating Margin -33.7%
FY 2019: -705.9%FY 2020: -619.4%FY 2021: -157.1%FY 2022: -107.6%FY 2023: -80.2%FY 2024: -43.0%FY 2025: -33.7%
FY 2019 5y median -80.2% FY 2025
Net Margin -31.0%
FY 2019: -680.4%FY 2020: -687.0%FY 2021: -173.6%FY 2022: -116.2%FY 2023: -77.8%FY 2024: -40.7%FY 2025: -31.0%
FY 2019 5y median -77.8% FY 2025
ROE -26.1%
FY 2019: -143.6%FY 2020: -87.0%FY 2021: -22.4%FY 2022: -44.2%FY 2023: -37.7%FY 2024: -22.7%FY 2025: -26.1%
FY 2019 5y median -26.1% FY 2025
ROIC -23.4%
FY 2019: -78.9%FY 2020: -40.6%FY 2021: -16.8%FY 2022: -29.2%FY 2023: -30.3%FY 2024: -20.0%FY 2025: -23.4%
FY 2019 5y median -23.4% FY 2025
ROA -18.8%
FY 2019: -67.7%FY 2020: -42.1%FY 2021: -17.8%FY 2022: -28.2%FY 2023: -26.2%FY 2024: -17.1%FY 2025: -18.8%
FY 2019 5y median -18.8% FY 2025

Growth (YoY)

Revenue 37.2%
FY 2019: 0.0%FY 2020: 25.1%FY 2021: 346.7%FY 2022: 117.6%FY 2023: 81.6%FY 2024: 64.8%FY 2025: 37.2%
FY 2019 FY 2025
Operating Income -7.5%
FY 2019: 0.0%FY 2020: -9.8%FY 2021: -13.3%FY 2022: -49.0%FY 2023: -35.2%FY 2024: 11.5%FY 2025: -7.5%
FY 2019 FY 2025
EPS (diluted) 1.7%
FY 2019: 0.0%FY 2020: -20.8%FY 2021: 9.3%FY 2022: -43.1%FY 2023: -14.3%FY 2024: 21.9%FY 2025: 1.7%
FY 2019 FY 2025
Free Cash Flow 43.7%
FY 2019: 0.0%FY 2020: 5.5%FY 2021: -19.2%FY 2022: -43.3%FY 2023: -60.4%FY 2024: 22.2%FY 2025: 43.7%
FY 2019 FY 2025

Financial Health

Current Ratio 6.8×
FY 2019: 7.4×FY 2020: 7.6×FY 2021: 20.1×FY 2022: 7.7×FY 2023: 7.6×FY 2024: 9.1×FY 2025: 6.8×
FY 2019 5y median 7.7× FY 2025
Quick Ratio 5.8×
FY 2019: 6.4×FY 2020: 7.1×FY 2021: 19.3×FY 2022: 6.9×FY 2023: 6.8×FY 2024: 8.0×FY 2025: 5.8×
FY 2019 5y median 6.9× FY 2025
Debt / Equity 0.2×
FY 2019: 0.8×FY 2020: 0.9×FY 2021: 0.2×FY 2022: 0.4×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.2×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA 2.4×
FY 2019: 0.5×FY 2020: 1.0×FY 2021: 4.9×FY 2022: 1.8×FY 2023: 1.8×FY 2024: 3.1×FY 2025: 2.4×
FY 2019 5y median 2.4× FY 2025
Interest Coverage -29.0×
FY 2019: -60.2×FY 2020: -9.1×FY 2021: -9.3×FY 2022: -15.6×FY 2023: -27.3×FY 2024: -23.1×FY 2025: -29.0×
FY 2019 5y median -23.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31